Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
Full metadata record
|dc.identifier.citation||International Journal of Neuropsychopharmacology, 2013; 16(7):1443-1459||en|
|dc.description.abstract||Dysfunction of dopamine D₃ receptors, particularly in the mesocorticolimbic system, has been linked to the pathogenesis of major depression. Preclinical data show enhanced D₃ receptor binding in the striatum upon antidepressant medication and electroconvulsive therapy (ECT). Thus, the potential impact of dopamine D₃ receptor gene (DRD3) variation on ECT outcome in treatment-resistant major depression was evaluated by applying a combined molecular and imaging genetic approach. Altogether, 10 representative variants covering 95.4% of DRD3 gene variation were investigated for association with response to ECT in a sample of 104 (71 female, 33 male) Caucasian patients with pharmacorefractory major depression. Additionally, ventral striatum responsiveness to happy faces was assessed in two independent samples of depressed patients (total N=54) by means of functional magnetic resonance imaging at 3 T. Significant association of DRD3 rs3732790, rs3773679 and rs9817063 variants with response (uncorrected p=0.02-0.03) and remission (uncorrected p=0.01) after ECT was discerned. Logistic regression analyses revealed association of rs3732790 (uncorrected p=0.009; corrected p=0.045) and rs3773679 (uncorrected p=0.009; corrected p=0.045) with remission when applying a recessive model of inheritance. The rs3732790T allele conferring a more favourable treatment response was furthermore found to be associated with stronger striatal responsiveness to happy facial expressions (sample 1: cluster-corrected p=0.002; sample 2: p=0.023). In summary, the present study suggests some impact of DRD3 gene variation on ECT response, potentially mediated by alteration of striatal engagement during the processing of emotionally rewarding stimuli.||en|
|dc.description.statementofresponsibility||Udo Dannlowski, Katharina Domschke, Eva Birosova, Bruce Lawford, Ross Young, Joanne Voisey, C. Phillip Morris, Thomas Suslow, Carsten Konrad, Harald Kugel, Patricia Ohrmann, Jochen Bauer, Sonja Schöning, Maxim Zavorotnyy, Julia Diemer, Volker Arolt, Bernhard T. Baune and Peter Zwanzger||en|
|dc.publisher||Cambridge Univ Press||en|
|dc.rights||© CINP 2011||en|
|dc.subject||Depression; DRD₃; electroconvulsive therapy; pharmacogenetics; ventral striatum.||en|
|dc.title||Dopamine D₃ receptor gene variation: impact on electroconvulsive therapy response and ventral striatum responsiveness in depression||en|
|dc.title.alternative||Dopamine D(3) receptor gene variation: impact on electroconvulsive therapy response and ventral striatum responsiveness in depression||en|
|dc.identifier.orcid||Baune, B. [0000-0001-6548-426X]||en|
|Appears in Collections:||Psychiatry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.